Core Alternative Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6K | Hold |
43
| – | – | 0.01% | 163 |
|
|
2025
Q1 | $27.3K | Hold |
43
| – | – | 0.01% | 160 |
|
|
2024
Q4 | $30.6K | Hold |
43
| – | – | 0.01% | 170 |
|
|
2024
Q3 | $45.2K | Hold |
43
| – | – | 0.01% | 149 |
|
|
2024
Q2 | $45.2K | Hold |
43
| – | – | 0.01% | 151 |
|
|
2024
Q1 | $41.4K | Sell |
43
-12
| -22% | -$11.6K | 0.01% | 152 |
|
|
2023
Q4 | $48.3K | Sell |
55
-6
| -10% | -$5.27K | 0.01% | 170 |
|
|
2023
Q3 | $50.2K | Hold |
61
| – | – | 0.01% | 181 |
|
|
2023
Q2 | $43.8K | Buy |
61
+2
| +3% | +$1.44K | 0.01% | 157 |
|
|
2023
Q1 | $48.5K | Buy |
59
+8
| +16% | +$6.57K | 0.01% | 160 |
|
|
2022
Q4 | $36.8K | Buy |
51
+1
| +2% | +$721 | ﹤0.01% | 176 |
|
|
2022
Q3 | $34K | Buy |
50
+3
| +6% | +$2.04K | 0.01% | 173 |
|
|
2022
Q2 | $28K | Buy |
47
+11
| +31% | +$6.55K | 0.01% | 193 |
|
|
2022
Q1 | $25K | Buy |
36
+32
| +800% | +$22.2K | 0.01% | 198 |
|
|
2021
Q4 | $3K | Buy |
+4
| New | +$3K | ﹤0.01% | 254 |
|